Douglas Berger Psychiatrist Tokyo

Douglas Berger psychiatrist Tokyo is an American board certified psychiatrist and is the Director of the Tokyo Meguro Counseling Center. He’s also fully bilingual in Japanese and English. Dr. Berger received his M.D. and psychiatry training from New York Medical College, and his Ph.D. from the Department of Psychosomatic Medicine at the Tokyo University School of Medicine. He speaks native-level Japanese. Dr. Berger utilizes a variety of approaches to psychiatry, which you can find here, and on the Tokyo Meguro Counseling Center’s home page.

Dr. Berger can be contacted by phone: 03-3716-6624 (+81-3-3716-6624 from outside of Japan). Please use this form if you wish to contact Dr. Douglas Berger psychiatrist in Tokyo.

> Dr. Berger’s credentials & publications can be found on this page.
> Click here for more information about his practice
> To read reviews from some of Dr. Berger’s patients.

Far from everyone on antidepressants gets antidepressant response even if the dose is high enough: Any patient can have a robust drug response, we just don’t know who that will be from a clinical trial of hundreds of persons. Us:

Douglas Berger, MD, PhD, Tokyo, Japan: 1.) New York Medical College Graduation Diploma; 2.) New York Medical College, Psychiatric residency Completion; 3.) U.S. Board-Certification in Psychiatry. Originals displayed in the Tokyo counseling office.


Neuro-chemicals of persons with psychosis is abnormal: That biochemical abnormalities exist in psychosis is strong: Many psychiatrists are calling for an overhaul of the bio-psycho-social model. Us:

iGen or the ("Internet Generation) is said to have a correlation of time on digital media and mental problems: Public shaming has more real-life negatives than just one's thoughts. Us:

Encapsulated cells may escape immune rejection: They can secrete molecules to treat many illnesses like diabetes, scarring, hemophilia, glaucoma, and others. Us:

Octopuses given MDMA-Ecstasy-began to act in-love with other octopuses: This suggests that human brain regions that produce this behavior wasn't developed until much later because Octopuses do not have these areas developed. Us:

Amber lens therapy is said to “work” for bipolar disorder: But this is only a preliminary unblinded case series with no blind placebo control. It is not yet valid to say Amber lens therapy works for bipolar disorder. Us:

800 gay participants shared 2 regions of the genome, 1 on the X chromosome & 1 on chromosome 8: Same-sex desire doesn’t lead to reproduction as frequently as opposite-sex desire so it must be a smaller % of the population. Us:

Load More...

No matter what the complexity of placebo and antidepressant mix is, the placebo group has an average placebo effect for the group, and the active drug has an active drug effect for the group. Individual responses are can not be clearly determined. Us:

Society can not expect universities to function as mental health clinics-and neither do they wish to be so: Universities’ main fear is of law suits due to morbidity and mortality of mentally disordered students. Us:

Stimulation of the Vagus & other nerves are treating headaches, opioid withdrawal, & possibly autoimmune-related diseases: The future of this modality is fascinating. Us:

AI is helping screen for potential for new drugs: AI helps go thru the vast possible molecules via "virtual libraries" of drug structures and properties. Great hope for the future. Us:

A Chinese study looked at ADHD risk w/diet. High minerals/protein (m/p) gave 47% reduced risk of ADHD:, 57% of low m/p had ADHD vs 39% of high m/p w/ADHD. 39% is still 68% of the 57%, so 68% on high m/p still had ADHD. Us:

There are no biologically measurables for psychiatric diagnoses: There is considerable overlap between criteria sets & even the DSMs do not purport to classify conditions based on etiology much less objective measures. Us:

DSM classifications attempt to avoid under or over diagnosing, reimbursement & special interest groups: Diagnostic names change over the generations of new DSMs with little concern for diagnostic validity. Us:

Do HLA testing before giving CBZ to Asians? Best not to give CBZ to Asians, or use oxcarbazepine. Until utility is proven, genetic tests should stay in the research lab or in drug development, not in clinical psychiatry. Us:

Load More...

This is a brave and articulate tweet stating the problems with simple tests. Us:

In psychiatry, as all endpoints are subjective, treatments are hard to prove without blinding: We tend to support psychotherapies with very low rigor of study as their clinical trials are unblinded. Us:

Body Temp isn't 98.6, it depends on time of day, gender, and method of measurement: The real value is closer to 97.7, slightly higher for women, peaking in late afternoon. People don't like the nuanced version of the world. Us:

Advanced diagnostics are at the forefront of medical treatment: A saliva test can identify endometriosis via microRNAs & disorders like autism, Parkinson's, and Alzheimer's are on the horizon. Us:

Female suicide rates are rising quickly in India: One cause may be that the opportunities for Indian women have not kept up with social and occupational advancement causing frustration and depression. Us:

EMDR: never had a single/double blind placebo study, is viewed as a non-specific, ineffective, an over-marketed scheme on patients and students paying for EMDR certificates: Also, see this Us:

Psychiatric practice is empirical, the results of treatment challenge and de-challenge along with longitudinal course follow-up can help with some level of diagnostic & treatment confidence, but these are by no means validating our classification. Us:

Psychiatric diagnoses are not proven entities that are tied to a clearly measurable parameter as is the case for example leukemia, stroke, MI, etc. All labels should be given with the caveat of poor objectivity of the psychiatric diagnostic system Us:

Load More...